Red blood cells inspire next-generation therapeutic nanocarriers

Automated news aggregation. Headlines and summaries are gathered from public feeds; see our editorial standards for sourcing, corrections, and AI-assist disclosure.

Red blood cells serve as the foundation for nanocarriers that show promise in a new study as effective and efficient vehicles for gene therapy, tumor targeting and other medical treatments. Scientists at The Ohio State University have showed that the engineered extracellular vesicles could evade immune cells and target cancer cells, two capabilities that could improve the delivery of future therapies. The study is published in Advanced Healthcare Materials.